Comparative cardiac toxicity in two treatment schedules of 5-FU/LV for colorectal carcinoma

被引:0
|
作者
Najam, Rahila [1 ]
Bano, Nusrat [1 ]
Mateen, Ahmed [2 ]
机构
[1] Univ Karachi, Fac Pharm, Dept Pharmacol, Karachi, Pakistan
[2] KIRAN, Karachi, Pakistan
关键词
Colorectal Carcinoma; Cardiac Toxicity; 5-FU; CPK; GOT; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR COMPLICATIONS; CANCER-THERAPY; 5-FLUOROURACIL; CARDIOTOXICITY; PATHOGENESIS; DIAGNOSIS; INFUSION; PATIENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of the study is evaluation and assessment of parameters of cardiac toxicity in patients subjected to 5-FU based chemotherapy. Cardiac morbidity is a reported outcome in different 5FU/LV regimens; however none of them are definite or proximate. The bimonthly regimen of high dose leucovorin is reported to be less toxic and more effective as compared to the monthly regimen of low dose leucovorin. We report the detailed assessment of few cardiac parameter of toxicity in patients of advanced colorectal carcinoma subjected to two Schedules of high and low dose Folinic Acid, 5-Fluorouracil, bolus and continuous infusion. The correlation of elevated cardiac biomarkers, angina and hypertension is comparatively assessed in patients with normal general status, hyperglycemia and known cardiac disorders subjected to two different 5FU based chemotherapeutic regimen.
引用
收藏
页码:1013 / 1022
页数:10
相关论文
共 50 条
  • [1] TREATMENT OF METASTATIC COLORECTAL-CARCINOMA WITH CISPLATIN AND 5-FU
    SHEPARD, KV
    FAINTUCH, J
    BITRAN, JD
    SWEET, DL
    ROBIN, E
    LEVIN, B
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 123 - 124
  • [2] 5-FU schedules, serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancer
    Blaschke, Martina
    Cameron, Silke
    Goeschen, Colin
    Ramadori, Giuliano
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 56 - 58
  • [3] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [4] SAFETY AND ACTIVITY OF AN ALTERNATINIG REGIMEN OF IRINOTECAN/5-FU/LV AND OXALIPLATIN/5-FU/LV (FAFOXIRI) IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCC)
    Amoroso, Vito
    Ferrari, Vittorio
    Valcamonico, Francesca
    Vassalli, Lucia
    Simoncini, Edda
    Grisanti, Salvatore
    Marpicati, Patrizia
    Rangoni, Giovanni
    Marini, Giovanni
    ANNALS OF ONCOLOGY, 2004, 15 : 62 - 63
  • [5] Phase II study of 5-FU/LV/lrinotecan in combination with regional hyperthermia (RHT) in 5-FU/Lv refractory patients with advanced colorectal cancer
    Krych, M
    Lindner, LH
    Abele, S
    Abdel-Rahman, S
    Fahn, W
    Milani, V
    Braun, S
    Stockheim, B
    Heinemann, V
    Issels, RD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 301S - 301S
  • [6] RANDOMIZED STUDY OF 2 DIFFERENT SCHEDULES OF METHYL CCNU, 5-FU AND VINCRISTINE FOR METASTATIC COLORECTAL CARCINOMA
    KEMENY, N
    YAGODA, A
    BRAUN, D
    GOLBEY, R
    CANCER, 1979, 43 (01) : 78 - 82
  • [7] TREATMENT OF METASTATIC COLORECTAL-CARCINOMA WITH 5-FU, MITOMYCIN, VINCRISTINE, AND METHOTREXATE
    BECK, TM
    CURTIS, PW
    WOODARD, DA
    HART, NE
    SMITH, CE
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 647 - 650
  • [8] Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancer
    Tsavaris, N
    Kosmas, C
    Gennatas, K
    Vadiaka, M
    Skopelitis, E
    Xila, V
    Rokana, S
    Margaris, E
    Zografos, G
    Papastratis, G
    Kouraklis, G
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (04) : 406 - 411
  • [9] No randomised comparative analysis of the acute toxicity of three different chemoradiotherapy schemes (Capecitabine, 5-FU and UFT) in colorectal carcinoma.
    Fernandez-Lizarbe, E.
    Molern, R.
    Veiras, M.
    Belinchon, B.
    Garcia-Berrocal, M. I.
    De la Torre, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81
  • [10] Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
    Falcone, A
    Pfanner, E
    Brunetti, I
    Allegrini, G
    Lencioni, M
    Galli, C
    Masi, G
    Danesi, D
    Antonuzzo, A
    Del Tacca, M
    Conte, PF
    TUMORI, 1998, 84 (06) : 666 - 668